1161975-56-9 Usage
Description
7-(Tributylstannyl)isoquinoline, a member of the isoquinoline family, is a unique chemical compound that features a tributylstannyl group attached to the 7-position of the isoquinoline ring. 7-(Tributylstannyl)isoquinoline is known for its versatility in organic synthesis and its potential pharmaceutical applications due to the presence of the isoquinoline structure, which is found in various bioactive molecules.
Uses
Used in Organic Synthesis:
7-(Tributylstannyl)isoquinoline is used as a precursor in organic synthesis for the creation of organic molecules with specific properties. The tributylstannyl group serves as a valuable leaving group in various reactions, facilitating the development of new compounds with tailored characteristics.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 7-(Tributylstannyl)isoquinoline is used as a starting material for the synthesis of isoquinoline derivatives. These derivatives have demonstrated potential in the treatment of certain diseases, making this compound an important tool in the discovery and development of new therapeutic agents.
Overall, 7-(Tributylstannyl)isoquinoline is a significant chemical in the field of organic chemistry, with applications spanning from the synthesis of novel organic molecules to the development of potential pharmaceuticals. Its unique structure and reactivity contribute to its value as a versatile building block in chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1161975-56-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,1,9,7 and 5 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1161975-56:
(9*1)+(8*1)+(7*6)+(6*1)+(5*9)+(4*7)+(3*5)+(2*5)+(1*6)=169
169 % 10 = 9
So 1161975-56-9 is a valid CAS Registry Number.
1161975-56-9Relevant articles and documents
ANGIOGENESIS INHIBITORS
-
Page/Page column 69, (2010/11/05)
Compounds of Structural Formula I or pharmaceutically acceptable salts thereof, are effective inhibitors of angiogenesis:
